Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation

Detalles Bibliográficos
Autores principales: Dimou, Anastasios, Ou, Sai-Hong I., Doebele, Robert C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450917/
https://www.ncbi.nlm.nih.gov/pubmed/32914039
http://dx.doi.org/10.1200/PO.19.00013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450917/
https://www.ncbi.nlm.nih.gov/pubmed/32914039
http://dx.doi.org/10.1200/PO.19.00013

Ejemplares similares